Literature DB >> 21549723

Reduced hippocampal activity during encoding in cognitively normal adults carrying the APOE ɛ4 allele.

Maheen M Adamson1, J Benjamin Hutchinson, Amy L Shelton, Anthony D Wagner, Joy L Taylor.   

Abstract

Apolipoprotein (APOE) ɛ4-related differences in memory performance have been detected before age 65. The hippocampus and the surrounding medial temporal lobe (MTL) structures are the first site affected by Alzheimer's disease (AD) and the MTL is the seat of episodic memory, including visuo-spatial memory. While reports of APOE ɛ4-related differences in these brain structures are not consistent in either cross-sectional or longitudinal structural and functional magnetic resonance imaging (fMRI) studies, there is increasing evidence that brain activity at baseline (defined as activity during fixation or rest) may differ in APOE ɛ4 carriers compared to non-carriers. In this fMRI study, cognitively normal APOE ɛ4 carriers and non-carriers engaged in a perspective-dependent spatial learning task (Shelton & Gabrieli, 2002) previously shown to activate MTL structures in older participants (Borghesani et al., 2008). A low-level, visually engaging dot-control task was used for comparison, in addition to fixation. APOE ɛ4 carriers showed less activation than non-carriers in the hippocampus proper during encoding. Specifically, when spatial encoding was contrasted against the dot-control task, encoding-related activation was significantly lower in carriers than non-carriers. By contrast, no ɛ4-related differences in the hippocampus were found when spatial encoding was compared with fixation. Lower activation, however, was not global since encoding-related activation in early visual cortex (left lingual gyrus) was not different between APOE ɛ4 carriers and non-carriers. The present data document APOE ɛ4-related differences in the hippocampus proper during encoding and underscore the role of low-level control contrasts for complex encoding tasks. These results have implications for fMRI studies that investigate the default-mode network (DMN) in middle-aged to older APOE ɛ4 carriers to help evaluate AD risk in this otherwise cognitively normal population.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549723      PMCID: PMC3137687          DOI: 10.1016/j.neuropsychologia.2011.04.022

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  65 in total

1.  Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs.

Authors:  B Richards; J Skoletsky; A P Shuber; R Balfour; R C Stern; H L Dorkin; R B Parad; D Witt; K W Klinger
Journal:  Hum Mol Genet       Date:  1993-02       Impact factor: 6.150

2.  Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele.

Authors:  H Soininen; K Partanen; A Pitkänen; M Hallikainen; T Hänninen; S Helisalmi; A Mannermaa; M Ryynänen; K Koivisto; P Riekkinen
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910

3.  Perirhinal and parahippocampal cortices of the macaque monkey: cortical afferents.

Authors:  W A Suzuki; D G Amaral
Journal:  J Comp Neurol       Date:  1994-12-22       Impact factor: 3.215

4.  Apolipoprotein E and cognitive performance: a meta-analysis.

Authors:  Brent J Small; Christopher B Rosnick; Laura Fratiglioni; Lars Bäckman
Journal:  Psychol Aging       Date:  2004-12

5.  Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers.

Authors:  Paul R Borghesani; L Clark Johnson; Amy L Shelton; Elaine R Peskind; Elizabeth H Aylward; Gerard D Schellenberg; Monique M Cherrier
Journal:  Neurobiol Aging       Date:  2007-03-09       Impact factor: 4.673

Review 6.  Searching for a baseline: functional imaging and the resting human brain.

Authors:  D A Gusnard; M E Raichle; M E Raichle
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

7.  Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots.

Authors:  Maheen M Adamson; Kelly M Landy; Susan Duong; Sabrina Fox-Bosetti; J Wesson Ashford; Greer M Murphy; Michael Weiner; Joy L Taylor
Journal:  Neurobiol Aging       Date:  2008-08-29       Impact factor: 4.673

Review 8.  The medial temporal lobe.

Authors:  Larry R Squire; Craig E L Stark; Robert E Clark
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

9.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

10.  Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer's disease and at-risk older individuals.

Authors:  Maija Pihlajamäki; Reisa A Sperling
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

View more
  17 in total

Review 1.  Genetics and functional imaging: effects of APOE, BDNF, COMT, and KIBRA in aging.

Authors:  Goran Papenberg; Alireza Salami; Jonas Persson; Ulman Lindenberger; Lars Bäckman
Journal:  Neuropsychol Rev       Date:  2015-02-10       Impact factor: 7.444

2.  Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriers.

Authors:  Wenjun Li; Piero G Antuono; Chunming Xie; Gang Chen; Jennifer L Jones; B Douglas Ward; Suraj P Singh; Malgorzata B Franczak; Joseph S Goveas; Shi-Jiang Li
Journal:  Cortex       Date:  2014-04-30       Impact factor: 4.027

3.  Genetic Variation of ApoE Gene in Ethnic Kashmiri Population and Its Association with Outcome After Traumatic Brain Injury.

Authors:  Adfar Yousuf; Nayil Khursheed; Ishrat Rasool; Vijay Kundal; Humira Jeelani; Dil Afroze
Journal:  J Mol Neurosci       Date:  2015-04-10       Impact factor: 3.444

Review 4.  Imaging markers of structural and functional brain changes that precede cognitive symptoms in risk for Alzheimer's disease.

Authors:  Alison Burggren; Jesse Brown
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

5.  Imaging the Alzheimer brain.

Authors:  J Wesson Ashford; Ahmad Salehi; Ansgar Furst; Peter Bayley; Giovanni B Frisoni; Clifford R Jack; Osama Sabri; Maheen M Adamson; Kerry L Coburn; John Olichney; Norbert Schuff; Daniel Spielman; Steven D Edland; Sandra Black; Allyson Rosen; David Kennedy; Michael Weiner; George Perry
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Distinct neural correlates of episodic memory among apolipoprotein E alleles in cognitively normal elderly.

Authors:  Hao Shu; Yongmei Shi; Gang Chen; Zan Wang; Duan Liu; Chunxian Yue; B Douglas Ward; Wenjun Li; Zhan Xu; Guangyu Chen; Qi-Hao Guo; Jun Xu; Shi-Jiang Li; Zhijun Zhang
Journal:  Brain Imaging Behav       Date:  2019-02       Impact factor: 3.978

Review 7.  Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction.

Authors:  Leo Ungar; Andre Altmann; Michael D Greicius
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

8.  Pilot expertise and hippocampal size: associations with longitudinal flight simulator performance.

Authors:  Maheen M Adamson; Peter J Bayley; Blake K Scanlon; Michelle E Farrell; Beatriz Hernandez; Michael W Weiner; Jerome A Yesavage; Joy L Taylor
Journal:  Aviat Space Environ Med       Date:  2012-09

9.  Mapping the Alzheimer's brain with connectomics.

Authors:  Teng Xie; Yong He
Journal:  Front Psychiatry       Date:  2012-01-05       Impact factor: 4.157

10.  APOE status modulates the changes in network connectivity induced by brain stimulation in non-demented elders.

Authors:  Cleofé Peña-Gomez; Cristina Solé-Padullés; Imma C Clemente; Carme Junqué; Núria Bargalló; Beatriz Bosch; José Luis Molinuevo; Josep Valls-Solé; Alvaro Pascual-Leone; David Bartrés-Faz
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.